Yinmo Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 48
- Pancreatic and Hepatic Oncology Research 42
-
- Cancer Genomics and Diagnostics 9
- MicroRNA in disease regulation 7
- Co-authors
- Xiaodong TianXuehai XieZhengkui ZhangMarko KornmannLing MaHuahu GuoFeng WangChong Du
- Journals
- Cancer Letters (7 papers)Frontiers in Oncology (4 papers)Journal of Cancer (4 papers)International Journal of Surgery (3 papers)Oncology Reports (3 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Yinmo Yang
72 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Cancer Research 428
- Oncology 560
- Molecular Biology 623
- Surgery 259
- Pulmonary and Respiratory Medicine 166
Countries citing papers authored by Yinmo Yang
This map shows the geographic impact of Yinmo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinmo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinmo Yang more than expected).
Fields of papers citing papers by Yinmo Yang
This network shows the impact of papers produced by Yinmo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinmo Yang. The network helps show where Yinmo Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yinmo Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 5 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 16 | |
| 11 | circKRT7-miR-29a-3p-COL1A1 Axis Promotes Ovarian Cancer Cell Progression | 2020 | 1 |
| 12 | 2020 | 3 | |
| 13 | Stanniocalcin 1 in tumor microenvironment promotes metastasis of ovarian cancer | 2019 | 1 |
| 14 | Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer | 2019 | 3 |
| 15 | 2019 | 12 | |
| 16 | 2017 | 0 | |
| 17 | 2016 | 74 | |
| 18 | 2014 | 9 | |
| 19 | 2013 | 24 | |
| 20 | 2012 | 14 |
About Yinmo Yang
Yinmo Yang is a scholar working on Oncology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Physiology, having authored 75 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (42 papers), Pancreatitis Pathology and Treatment (15 papers), Cancer Genomics and Diagnostics (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), MicroRNA in disease regulation (7 papers), Renal cell carcinoma treatment (6 papers), Neuroendocrine Tumor Research Advances (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Cancer Research (428 citations), Oncology (560 citations), Molecular Biology (623 citations), Surgery (259 citations) and Pulmonary and Respiratory Medicine (166 citations). Yinmo Yang has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Xiaodong Tian, Xuehai Xie, Zhengkui Zhang, Marko Kornmann, Ling Ma, Xiaodong Tian, Huahu Guo, Feng Wang, Chong Du and Yongsu Ma. Their work appears in journals such as Cancer Letters, Frontiers in Oncology, Journal of Cancer, International Journal of Surgery and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.